The best way to start Wegovy: what actually matters in the first weeks

The myth that stops people getting the start right

A question our prescribers hear most weeks goes something like this: "I've been on Wegovy for three weeks and haven't lost much weight, should I move to a higher dose?" The underlying assumption is that the starter dose is the working dose, and that slow early results signal a problem.

It isn't, and they don't.

The 0.25 mg starting dose exists purely to reduce the chance of nausea, vomiting and other gastrointestinal discomfort. The NHS semaglutide information page is clear that treatment begins at 0.25 mg weekly for the first four weeks before any increase. Skipping steps or self-escalating doesn't accelerate results, it raises the likelihood of side effects severe enough to interrupt treatment entirely. Patience at the start is not passive; it is the mechanism.

The other version of this myth is that Wegovy does all the work on its own. In clinical trials, participants followed a reduced-calorie diet and increased their physical activity alongside the injection. The licence specifically reflects that combination. The medicine reduces appetite and slows gastric emptying; the lifestyle changes direct what happens in that narrowed appetite window.

What the first four weeks actually look like

After your first injection the most noticeable changes tend to be physical rather than on the scales. Appetite often drops more sharply than expected, many people find they feel full after noticeably smaller portions from the first week. Nausea is common, particularly in the 24–48 hours after each injection, and tends to peak around days two or three before settling. Eating smaller meals, choosing lower-fat options and avoiding lying down immediately after eating all reduce that discomfort in practice.

Picking a consistent injection day helps build the habit reliably, and if you want to think carefully about which day of the week works best when starting Wegovy, there is guidance to help you plan around your routine. Similarly, some people find injection timing within the day makes a difference to how manageable any nausea is, that question is covered on the best time of day to start Wegovy page.

Weight loss in the first four weeks varies significantly from person to person and is not a reliable indicator of long-term response. The STEP 1 trial, published in the New England Journal of Medicine, reported an average of around 15% body-weight reduction over 68 weeks at the 2.4 mg maintenance dose, a result built across the entire course, not the first month.

Practical habits that make the starting period easier

Three things consistently affect how comfortable the early weeks feel. The first is meal size. Because Wegovy slows how quickly the stomach empties, eating as you normally would can cause uncomfortable fullness or reflux. Smaller, more frequent meals sidestep this. The second is protein. Reduced appetite means reduced intake overall; prioritising protein helps preserve muscle while the body adapts. The third is hydration. Nausea and reduced appetite can both suppress the urge to drink, staying on top of fluids matters, particularly if you experience vomiting or diarrhoea in the early days.

Alcohol is worth mentioning separately. It interacts poorly with an already-sensitive stomach in the early weeks and can lower blood sugar more readily when appetite is suppressed. Reducing or pausing alcohol, at least at the start, is a practical step rather than a dramatic one.

If you're also weighing up what the treatment costs over time, the weight-loss treatment overview gives context on the full picture. Storage is straightforward: Wegovy pens are kept refrigerated between 2 and 8°C, and if you want to plan carefully around which day makes the most sense to begin Wegovy, that page walks through the practical considerations worth factoring in before you take your first dose.

When to raise concerns rather than wait

Most early side effects are GI-led and transient. Some aren't. Severe, persistent stomach pain that spreads toward the back (with or without vomiting) needs prompt medical attention, as it can signal acute pancreatitis. The MHRA highlighted this in its January 2026 Drug Safety Update on GLP-1 medicines, which is worth being aware of before starting. Signs of an allergic reaction, significant swelling, or any sudden visual changes also warrant urgent contact with a healthcare professional rather than a watchful wait.

If something feels wrong with your dose, timing or tolerability, the right step is to speak to your prescriber rather than adjust independently. Stopping Wegovy abruptly, or deciding the dose isn't working without clinical input, tends to produce outcomes worse than the discomfort that prompted the thought, there's a fuller look at how to stop Wegovy safely if that becomes relevant later. All of this is also part of why the clinical relationship at the start of treatment matters: a prescriber who knows your history can tailor the start in ways a self-managed approach cannot.

If you'd like to understand more about semaglutide as the medicine behind Wegovy, or explore how to access Wegovy through a regulated UK pharmacy, those pages go into the specifics. When you're ready to speak to a prescriber, starting a free consultation with our clinical team is the first step.